Enanta Pharmaceuticals is a clinical stage biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs for viral infections and liver diseases. Enanta’s research and development is currently focused on the following disease targets: respiratory syncytial virus (RSV), SARS-CoV-2 (C0VID-19), hepatitis B Virus (HBV) and human metapneumovirus (hMPV).

Learn More »


Data Provided by Refinitiv. Minimum 15 minutes delayed.

Recent Press Releases

May 31, 2023
Enanta Pharmaceuticals to Participate at Jefferies Global Healthcare Conference
May 9, 2023
Enanta Pharmaceuticals to Participate in Two Investor Conferences in May

Upcoming Events